Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate | CAS:769195-26-8

We serve Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate CAS:769195-26-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate

Chemical Name:Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate
CAS.NO:769195-26-8
Synonyms:Benzenebutanoic acid, 2,4,5-trifluoro-β-oxo-, methyl ester
Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate
3-OXO-4-(2,4,5-TRIFLUORO-PHENYL)-BUTYRIC ACID METHYL ESTER
Molecular Formula:C11H9F3O3
Molecular Weight:246.18300
 
Physical and Chemical Properties:
Density:1.331
Boiling point:273.265ºC
Flash point:115.458ºC
 
HS Code: 2918300090
 
Specification:
Appearance:Off-white to beige to yellow solid
Purity(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Sitagliptin
 
Note:The product under valid patents will not be offered to the countries covered by patents.



Contact us for information like Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-OXO-4-(2,4,5-TRIFLUORO-PHENYL)-BUTYRIC ACID METHYL ESTER physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate Use and application,3-OXO-4-(2,4,5-TRIFLUORO-PHENYL)-BUTYRIC ACID METHYL ESTER technical grade,usp/ep/jp grade.


Related News: The Transport Security Administration (TSA) will issue a new security directive to airlines from Sunday, according to a person briefed on the restrictions.4-Pentyloxyphenylboronic acid manufacturer In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.3-Bromo-5-fluoro-2-methoxypyridine supplier In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.methyl (3S)-3-hydroxytetradecanoate vendor Here’s what we can tell you so far:Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase.